Centrica PLC Transaction in Own Shares (9229T)
22 März 2023 - 7:10PM
UK Regulatory
TIDMCNA
RNS Number : 9229T
Centrica PLC
22 March 2023
Transactions in own shares
Centrica plc
22 March 2023
Centrica plc announces that today it purchased (through Goldman
Sachs International) 4,025,152 Centrica plc ordinary shares of 6
(14) /(81) pence each at a price of 102.6000 pence per share. The
purchased shares will be held as treasury shares. Such purchase was
effected pursuant to the Company's buyback programme (details of
which were as announced on 15 November 2022) and effected in
accordance with the non-discretionary share repurchase agreement
entered into with Goldman Sachs International, as announced on 15
November 2022.
Since 15 November 2022, Centrica has purchased 225,513,875
ordinary shares at a cost (excluding dealing and associated costs)
of GBP224,170,066.87.
Following the above purchase, Centrica plc holds 225,290,962
ordinary shares in treasury, and has 5,682,555,176 ordinary shares
in issue (excluding treasury shares).
In accordance with Article 5(1)(b) of Regulation (EU) No
596/2014 (the Market Abuse Regulation) (as in force in the UK and
as amended by the Market Abuse (Amendment) (EU Exit) Regulations
2019), detailed information about the individual purchases made by
Goldman Sachs International is set out below.
Transaction details: Centrica plc ordinary shares of 6 (14)
/(81) pence each
Issuer name: Centrica plc
ISIN: GB00B033F229
Intermediary name: Goldman Sachs International
Intermediary Code: GSILGB2XXXX
Currency: GBP
Aggregated information
Date of purchase: 22 March 2023
Number of ordinary shares purchased: 4,025,152
--------------
Highest price paid: 103.7500
--------------
Lowest price paid: 101.3500
--------------
Volume weighted average price paid
per share: 102.6000
--------------
Disaggregated information
The table attached contains detailed information of the
individual trades made by Goldman Sachs International, as part of
the buyback programme.
Click on, or paste the following link into your web browser, to
view the associated PDF document.
http://www.rns-pdf.londonstockexchange.com/rns/9229T_1-2023-3-22.pdf
END
Enquiries:
Investors and Analysts
T: 01753 494900
E: ir@centrica.com
Centrica plc is listed on the London Stock Exchange (CNA)
Registered Office: Millstream, Maidenhead Road, Windsor,
Berkshire SL4 5GD
Registered in England & Wales number: 3033654
Legal Entity Identifier number: E26EDV109X6EEPBKVH76
ISIN number: GB00B033F229
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
POSFZGZFNZRGFZM
(END) Dow Jones Newswires
March 22, 2023 14:10 ET (18:10 GMT)
Centrica (LSE:CNA)
Historical Stock Chart
Von Sep 2024 bis Okt 2024
Centrica (LSE:CNA)
Historical Stock Chart
Von Okt 2023 bis Okt 2024